Betulin Market Report Scope & Overview:

The Betulin Market was valued at USD 976.80 Million in 2025 and is expected to reach USD 1.90 Billion by 2035, growing at a CAGR of 6.90% from 2026-2035.

Betulin is a triterpene compound of pentacyclic nature that is derived from the bark of the birch tree, owing to its abundant presence, which makes the extraction process feasible enough to use as a by-product of forestry and plywood industry. Some of the qualities of betulin include anti-inflammatory, antimicrobial, and skin barrier protective activity. Moreover, betulin acts as an important precursor for betulinic acid that is under exploration for oncological and antiviral uses. The market demand is mostly due to the use of betulin in personal care products manufactured by companies in cosmetics industries. Other applications include use in pharmaceutical and nutraceutical studies. The availability of supply sources depends a lot on forestry by-products.

U.S. Betulin Market Outlook

The U.S. Betulin Market was valued at USD 190.96 Million in 2025 and is expected to reach USD 351.78 Million by 2035, growing at a CAGR of 6.30% from 2026-2035.

National demand is split between cosmetics formulators sourcing betulin as a soothing and anti-aging active and a smaller but growing pharmaceutical research base evaluating betulinic acid derivatives for oncology and antiviral indications. Nutraceutical ingredient suppliers and contract manufacturers concentrated in California and the Upper Midwest continue to expand botanical extract portfolios through acquisition, broadening the range of formats available to downstream customers without requiring each company to build independent extraction capacity. Clean-label and naturally derived ingredient preferences among American consumers continue to support reformulation activity that favors established, well-characterized botanical actives such as betulin over newer, less-substantiated alternatives.

By Source, Birch Trees Dominates the Betulin Market and Others Grows Fastest

Birch trees remain the dominant source of commercial betulin, accounting for an estimated 85.0 percent of global revenue in 2025, reflecting decades of established extraction infrastructure built around the forestry and plywood industries of Northern Europe, Russia, and parts of North America. Birch bark has traditionally been treated as a low-value residue burned for energy recovery, which means producers with dedicated extraction capacity can source feedstock at a comparatively low input cost relative to purpose-grown botanical alternatives.

Other botanical sources, such as hazel bark, calendula and alder, are the fastest growing source category as ingredient suppliers diversify feedstock to reduce dependence on birch processing regions and support marketing claims linked to specific botanical origins favored by premium cosmetics brands. These other sources typically have lower betulin concentrations than birch bark, which keeps unit costs high, but suppliers have found a receptive customer base among formulators seeking differentiated ingredient stories outside the dominant birch-derived supply chain. Some suppliers also position these alternative sources as a hedge against future feedstock constraints, should birch-processing volumes in any single region ever decline.

⮞In October 2025, researchers from Universidade Estadual de Goiás and Universidade Evangélica de Goiás, Brazil, published a study isolating betulin from Miconia burchellii, a plant native to the Brazilian Cerrado, and characterized its molecular structure using single-crystal X-ray diffraction and computational modelling.

By Application, Personal Care & Cosmetics Dominates the Betulin Market and Pharmaceuticals Grows Fastest

Personal Care and Cosmetics is the leading application for betulin, accounting for an estimated 33.0 percent of global revenue in 2025, as the substance is used in the development of moisturizers, after-sun lotions, and anti-aging serums that are sold as being soothing and protective in nature. The extensive background that betulin has as a natural component of skin care products, in addition to its clear safety record, makes it a suitable ingredient for those companies that are interested in backing up their claim of gentleness.

Pharmaceuticals is the fastest-growing application, driven by sustained research interest in betulinic acid, a direct derivative of betulin under investigation for oncology and antiviral indications. Most pharmaceutical research programs remain in preclinical or early clinical stages, which keeps absolute volumes smaller than the cosmetics channel, but steady academic and contract research demand for pharmaceutical-grade betulin as a starting material is supporting above-average growth in this application relative to the broader market. Specialized suppliers that can document consistent impurity profiles across production batches are best positioned to capture this research-driven demand over the remainder of the forecast period.

⮞In October 2025, researchers from Guangzhou Medical University in China published findings demonstrating that betulin suppressed tumor growth and angiogenesis in non-small-cell lung cancer models by inhibiting the PAX2/VEGF-A/VEGFR2 signaling pathway, highlighting its potential for pharmaceutical drug development.

By Form, Fine Powder Dominates the Betulin Market and Liquid Solution Grows Fastest

Fine Powder is the leading product form, accounting for an estimated 54.0 percent of market revenue, reflecting its long shelf-life, ease of transport and compatibility with established manufacturing processes used across cosmetic, pharmaceutical and nutraceutical production lines. Powder-form betulin does not require special storage conditions in most distribution environments, keeping logistics costs manageable for buyers with multiple regional warehouses, and supporting its continued use as the default purchasing format in long-term supply agreements with large-volume customers. Contract manufacturers also favor the powder format because it allows precise gravimetric dosing into batch formulations across cosmetics, nutraceutical, and pharmaceutical research production lines alike.

Liquid Solution formats are the fastest-growing form, as cold-process cosmetics formulators increasingly favor ready-to-use concentrates that eliminate an in-house dissolution step. Ingredient suppliers that have developed gel and oleogel formats are finding a receptive customer base among smaller cosmetics brands that lack dedicated high-shear mixing equipment, since pre-dispersed liquid formats are easier to incorporate consistently into finished emulsions without introducing undissolved particulates. Suppliers have responded by expanding liquid-concentrate product lines aimed specifically at smaller and mass-market beauty brands that lack in-house formulation chemistry teams of their own.

⮞In 2026, researchers from Abhilashi University in India published a study developing a betulin-loaded nanoemulsion gel for topical psoriasis treatment, using formulation optimization to achieve uniform particle distribution and a drug-loading capacity of approximately 21.17%, addressing betulin's formulation challenges.

By Purity Grade, Cosmetic Grade Dominates the Betulin Market and Pharmaceutical Grade Grows Fastest

The demand for purity grade is driven by cosmetic grade, due to the dominant position of the application segment and the relatively lower purification requirements needed to meet the cosmetics regulatory standards compared to pharmaceutical-grade specifications. The large multinational personal care companies with high-volume production lines at multiple manufacturing sites continue to specify cosmetic-grade material as their standard input, due to its favorable cost position relative to higher-purity alternatives. The dominant position of cosmetic-grade material within the formulation industry is underpinned by established supplier relationships and long-term purchasing agreements.

Pharmaceutical Grade betulin is the fastest-growing purity category, driven by rising research requirements for very high-purity raw material, which is perfect for the preparation of betulinic acid derivatives. Research initiatives in oncology and antiviral therapies require precise impurity profiles, which is achieved by just a few specialist suppliers, thus allowing pharmaceutical-grade producers to have an advantage in this niche market, which is growing fast but remains rather small. Additional research funding at universities and contract research organizations will certainly drive this growth in the rest of the forecast period.

⮞In April 2026, researchers published a study demonstrating the extraction of betulin from birch bark using natural deep eutectic solvents, with a choline chloride–fructose formulation achieving 243.32 mg of betulin per gram of dry extract and analytical characterization supporting further development of purified botanical ingredients.

Regional Analysis

North America Betulin Market Insights

North America is the third-largest regional market, with an estimated 23.00 percent share in 2025, anchored by a cosmetics manufacturing base in the United States alongside a growing pharmaceutical research sector evaluating betulinic acid derivatives for oncology applications. Canada contributes a smaller but stable share of regional consumption, driven by personal care contract manufacturers serving both local retail brands and export customers. Regional demand also benefits from established forestry byproduct recovery infrastructure in parts of the northern United States, where birch processing has historically been a byproduct of timber and plywood operations.

Nutraceutical ingredient suppliers in California and the Upper Midwest continue to consolidate through acquisition, combining complementary botanical extract portfolios to broaden the formats available to downstream customers. International personal care and natural ingredient brands with significant North American retail presence are also supporting regional demand, as clean-label consumer preferences continue to favor well-characterized botanical actives such as betulin over newer, less-substantiated synthetic alternatives entering the broader skin care category. Pharmaceutical-grade material is still seeing incremental demand from pharmaceutical research institutions across the region as betulinic acid derivative programs move through early stage investigation.

Asia Pacific Betulin Market Insights

Asia Pacific is the second-largest regional market by share but the fastest-growing region overall, with a CAGR of 8.70 percent from 2026-2035, supported by China's position as the largest national market within the region and by expanding cosmetics manufacturing capacity across India, Japan, and South Korea. China's production of specialty botanical extracts continues to scale, while rising consumer interest in traditional and natural ingredient positioning across the region supports steady formulation demand for betulin-containing personal care products alongside established synthetic actives. Regional forestry operations in parts of Northeast Asia are also beginning to evaluate birch bark valorization programs similar to those already established in Northern Europe.

India has emerged as a particularly active growth pocket, with venture-backed botanical ingredient companies attracting new financing to scale natural extract production for both local and export customers. Japan continues to serve as an innovation center for premium skin care formulations incorporating botanical actives such as betulin, and several Japanese personal care companies have reported steady earnings even amid broader volatility in regional consumer spending patterns across different national markets within Asia Pacific. South Korea's cosmetics exporters are also expanding their botanical active ingredient portfolios to serve both regional and international customers.

⮞In February 2026, researchers from Sichuan Agricultural University and Nanchang University published findings demonstrating that betulin activates hepatic PPARα-FGF21 signaling associated with improvements in obesity-related metabolic disorders, expanding scientific interest in its potential applications in pharmaceutical and nutraceutical research.

Europe Betulin Market Insights

With a share of 37.50 percent in 2025, Europe led the market, supported by Germany as the dominant national consumer and well-developed facilities for birch wood processing located in the Baltic countries, Russia, and Scandinavia. European producers of specialized chemicals and botanical ingredients hold a share of global betulin extraction capacity that is large relative to the continent’s share of global cosmetics sales, owing to the long-standing tradition of investing in processing waste from forest products in the timber and plywood industries. European legislation on the safety and labeling of cosmetic ingredients is considered a model by international companies and stimulates the use of botanical formulas in Europe.

Natural and botanical-positioned cosmetics brands based in Switzerland, France, and Germany continue to expand product lines built around well-characterized plant actives, supporting steady consumption growth even as some companies report mixed profitability across different business divisions. Dermatocosmetics and pharmacies available in the region still opt for well-known plant-based active ingredients with a history of proven safety, making consumers confident about formulas containing ingredients such as betulin together with novel specialty actives. Some of the brands in the region are even putting effort into re-substantiating their clinical claims based on these traditional plant actives.

⮞In February 2026, researchers involving Mid Sweden University and European research institutions published an optimized ultrasound-assisted extraction method for betulin from silver birch bark, achieving 34.63 mg of betulin per gram of bark with repeatability below 5%, supporting more efficient forestry-residue valorization.

MEA & Latin America Betulin Market Insights

The Middle East and Africa is a smaller but steadily growing market for betulin, with an estimated 7.50 percent share in 2025, and South Africa serving as the region's largest national market given its established base of natural and active cosmetics ingredient exporters. Government-backed export promotion programs have supported South African ingredient companies in showcasing natural and active cosmetics ingredients at major international trade events, helping regional suppliers build relationships with multinational personal care buyers seeking diversified, non-European botanical sourcing options.agencies continue to coordinate pavilion participation at successive trade fairs to sustain this momentum into future cycles.

Latin America represented a smaller 5.50 percent share in 2025, with Brazil as the region's largest national market given its sizeable local cosmetics industry and well-established natural-ingredient positioning among local personal care brands. Regional contract manufacturers in Colombia and other markets are also expanding capacity and pursuing new export relationships, partly in response to shifting trade dynamics affecting ingredient and finished-product sourcing routes across the broader Latin American region. Brazilian ingredient companies are additionally pursuing technology partnerships aimed at discovering and commercializing new bioactive complexes sourced from the Amazon region.

Market Dynamics

Growth Drivers: Rising demand for birch bark-derived actives in skin care and pharmaceutical research is expanding betulin use

Betulin demand is supported by its use as a skin-protective, anti-inflammatory active in moisturizers, after-sun products and barrier-repair creams, where formulators value its natural origin as a forestry by-product. Plywood and forestry processors in Northern Europe are adding dedicated bark extraction capacity, which gives cosmetics and pharmaceutical customers a more reliable supply of standardized betulin and birch triterpene extracts.

A second driver is pharmaceutical validation of birch triterpenes. The approval of Filsuvez, a birch bark-based topical gel for epidermolysis bullosa, in the United States and the European Union, followed by its registration in Australia in May 2026, shows a regulatory path for betulin-containing extracts and supports research interest in betulinic acid and related derivatives as development candidates.

⮞In May 2026, South Korea's SEORIN Company published results from a pilot randomized, double-blind clinical trial evaluating its betulin-loaded arginine-caprylate self-assembly formulation, demonstrating improvements in skin elasticity, brightness and protection against UV- and heat-induced skin damage.

Restraints: Feedstock concentration and purification costs limit supply flexibility

Commercial betulin supply depends on birch bark from a limited number of forestry and plywood regions, so output follows timber industry volumes rather than demand for the ingredient. Extraction and purification to cosmetic or pharmaceutical purity add solvent, energy and quality-control costs, which keeps prices high for price-sensitive buyers.

A second restraint is that most pharmaceutical programs based on betulinic acid remain at the preclinical or early clinical stage, so volume demand from this channel is slow to build. Smaller extractors also face costs in documenting consistent impurity profiles across batches, which larger, integrated producers can absorb more easily.

Opportunities: AI-driven discovery platforms are creating new paths to ingredient innovation

AI-based approaches to identifying botanical ingredients are an important avenue to explore for betulin manufacturers and their research partners who are prepared to combine their experience in conventional extraction techniques with modern computational techniques for screening purposes. Companies that use AI to discover new ingredients are seeking partnerships with ingredient manufacturing companies in order to discover and develop new bioactive complexes, forming new partnership opportunities that conventional triterpene providers are just beginning to explore. Conventional ingredient manufacturers who work with the companies developing AI discovery technology will have an early opportunity to explore new bioactive complexes.

A second opportunity lies in positioning betulin and related birch-derived triterpenes within broader longevity and skin-health platforms, where suppliers stand to capture disproportionate value as personal care brands increasingly market products on scientifically substantiated healthy-aging claims. Partnerships between regional natural ingredient producers and technology-driven discovery platforms are expected to accelerate over the next several years as both sides seek to combine traditional botanical knowledge with modern scientific validation methods. Brands that can credibly connect a well-established active such as betulin to newly discovered complementary ingredients stand to differentiate their formulations most effectively.

⮞In March 2026, Evra Ingredients and Brightseed announced a collaboration integrating Brightseed's Forager AI platform into botanical ingredient discovery, enabling the identification of differentiated plant-based bioactive compounds and creating opportunities for ingredient manufacturers to develop scientifically differentiated natural formulations.

Betulin Market Key Players

• Otto Chemie Pvt. Ltd.

• SimSon Pharma Limited

• ChemFaces

• Aktin Chemicals, Inc.

• Hovane Phytochemicals

• Latvijas Finieris AS

• Tianjin NWS Biotechnology and Medicine Co. Ltd.

• Betulin Lab (Latvijas Finieris Group)

Betulin Market Report Scope: